CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex

  1. Krzysztof Masternak1,
  2. Annick Muhlethaler-Mottet1,
  3. Jean Villard1,
  4. Madeleine Zufferey1,
  5. Viktor Steimle2, and
  6. Walter Reith1,3
  1. 1Department of Genetics and Microbiology, University of Geneva Medical School, 1211 Geneva, Switzerland; 2Hans-Spemann-Laboratories, Max-Planck-Institute of Immunology, D-79108 Freiburg, Germany

Abstract

By virtue of its control over major histocompatibility complex class II (MHC-II) gene expression, CIITA represents a key molecule in the regulation of adaptive immune responses. It was first identified as a factor that is defective in MHC-II deficiency, a hereditary disease characterized by the absence of MHC-II expression. CIITA is a highly regulated transactivator that governs all spatial, temporal, and quantitative aspects of MHC-II expression. It has been proposed to act as a non-DNA-binding transcriptional coactivator, but evidence that it actually functions at the level of MHC-II promoters was lacking. By means of chromatin immunoprecipitation assays, we show here for the first time that CIITA is physically associated with MHC-II, as well asHLA–DM, Ii, MHC-I, and β2mpromoters in vivo. To dissect the mechanism by which CIITA is recruited to the promoter, we have developed a DNA-dependent coimmunoprecipitation assay and a pull-down assay using immobilized promoter templates. We demonstrate that CIITA recruitment depends on multiple, synergistic protein–protein interactions with DNA-bound factors constituting the MHC-II enhanceosome. CIITA therefore represents a paradigm for a novel type of regulatory and gene-specific transcriptional cofactor.

Keywords

Footnotes

  • 3 Corresponding author.

  • E-MAIL Walter.Reith{at}medecine.unige.ch; FAX 41-22-7025702.

    • Received December 10, 1999.
    • Accepted March 15, 2000.
| Table of Contents

Life Science Alliance